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Abstract
pH-sensitive Oxygen Release Microspheres to Enhance Cell Survival in Ischemic Condition
by
Zhongting Liu
Master of Material Science of Engineeing
Washington University in St. Louis, 2019
Professor Jianjun Guan
Ischemic diseases such as myocardial infarction, stroke and limb ischemia are severe
cardiovascular diseases with high rate of death and millions of people suffered from these diseases.
Under ischemic environment, cells die due to deficient supply of nutrient and oxygen. To
regenerate ischemic tissues, stem cell therapy is a promising approach because stem cells can
differentiate into cells necessary for the regeneration. However, stem cell therapy has limitations.
For example, few cells can survive under harsh ischemic environment. To enhance stem cells
survival, implantation of oxygen release microspheres to sustained supply cells with oxygen
represents an effective strategy. Previously, our laboratory has developed a series of oxygen
release microspheres. While these microspheres augmented cell survival, their oxygen release
kinetics is not yet ideal as the oxygen release is not responsive to local pH in tissues. In this
research, we have synthesized pH sensitive shells for tailoring oxygen release under pH condition
of the ischemic tissues. We find the microspheres can release oxygen faster in specific pH
condition with pH sensitive shells. With oxygen release microspheres, cell survival was highly
enhanced after incubation under ischemic condition for 14 day.

xi

Chapter 1 :Approaches to Enhance Cell
Survival in Ischemic Condition
1.1 Introduction to Ischemic Diseases
Ischemic diseases are caused by reduced blood flow, which subsequently reduces oxygen and
nutrient supply. Because of deficient supply of essential elements, cells die and tissues are
damaged. It occurs in nearly all solid organs and tissues, which causes high morbidity, disability
and mortality [1].

According to the statistics, ischemic heart disease (IHD) has excessively high morbidity and
mortality in the United States [2]. Under ischemic environment, normal cell metabolism is
hindered by deficient oxygen and nutrients. In heart tissues, after a long period of ischemic
condition, cardiomyocytes are dead, followed by cardiac tissue necrosis. With therapeutic
advances, drug medical treatment is an effective method for patients that are not suitable for
percutaneous or surgical revascularization [3]. However, the medical treatment only focuses on
rescuing interruption in blood vessels and recovers the reperfusion but fails to regenerate cardiac
tissues and their biofunction. As a result, the medical treatment may cause ischemia-reperfusion
injury, a detrimental effect where the reperfusion blood induces additional lesions.

The ischemic stroke may cause traumatic brain injury and lead to critical disability. Due to the
clotting in blood vessels, the sudden decrease in blood flow and oxygen supply to brain tissue
causes dysfunction of the mitochondria. Although there are multiple developing drugs and
treatment for saving ischemic brain, the efficacy is not optimal. Millions of patients especially
elders suffer from the disease and efficient therapeutic strategies are needed [4].
1

The critical limb ischemia, defined as the reduction of limb blood perfusion, is the ultimate and
most severe form of peripheral artery disease [5]. Patients with critical limb ischemia are facing
high risk of amputation. Despite the rarity of 1% to 3% of over 8 million Americans having
peripheral artery disease, society has spent much health care utilization on curing ischemic limb
disease [6].

1.2 Stem Cell Therapy
Cells transplantation is one of the therapeutic strategies to treat ischemic diseases. Stem cells are
multipotent and can differentiate into various cell types and restore tissue functions while
transplanted into ischemic tissues. For the ischemic heart diseases, transplanting donor
cardiomyocytes to integrate host myocardium can increase myocardial mass and strengthen
systolic function. After transplanting fetal cardiomyocytes suspension into injured adult hearts,
they formed stable grafts and differentiated and secreted many molecular and morphological
factors that is typical in normal adult cardiomyocytes. Additionally, previous study found that even
non-cardiomyogenic cells can also restore myocardium function, which demonstrated diverse
chances for ischemic heart diseases curing [7].

In clinical use and research study, stem cells therapy has attracted more attention in various stem
cell types. For example, induced pluripotent stem cells (IPSCs), mesenchymal stem cells (MSCs),
cardiac stem cells (CSCs) and embryonic stem cells (ESCs) have been studied and used [8].

1.2.1 Bone Marrow Derived Stem Cells and Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) have the ability of self-renewal and multiple differentiation,
which attracted researches on studying MSCs on restoring organs tissues pre-clinically. As for
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ischemic heart diseases, by improving vascularization and restoring heart tissue functions,
researchers have completed the restoration in vivo study [9-10]. Bone marrow derived stem cells
especially bone marrow derived mesenchymal stem cells have ability to transdifferentiate to
cardiomyocytes to integrate myocardium and restore tissue functions [11-13].

Ana et al injected human bone marrow mesenchymal stem cells (BMSCs) into infarcted nude rats
and analyze cardiac function by echocardiography to study the effect of BMSCs on healing of
infarcted hearts. The results showed that the BMSCs induced an improvement in left ventricular
cardiac function and proliferation of cells in infarction tissue [14].

As for brain tissue damage caused by stroke in brain, due to MSCs can differentiate into neural
cells, MSCs therapeutic method is a potential treatment for neurological disorder by restoring the
tissue function and curing brain damage [15].

In ischemic limb diseases, patients suffered from severe pain and high risk of disability even death.
Holger L et al pointed out that with several trials of using bone marrow derived stem cells for
atherosclerotic peripheral artery disease treatment, BSCs seems to be a promising way for ischemic
limb diseases by reduction of patients’ pain and decreasing necessities for amputation [16].

1.2.2 Embryonic Stem cells
Embryonic stem cells (ESCs) are separated from embryo and can proliferate and differentiate into
any type of cells in body because ESCs are pluripotent. With the potential utilization for stem cells
transplantation, studies of ESCs have been processed for years. In curing ischemic heart diseases,
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with the pluripotent specialty in cells differentiation into cardiomyocytes and unlimited
proliferation, ESCs improved myocardium cells proliferation and restored damaged tissue function.

Arnoud C F et al studied the ESCs differentiation in vitro gene expression and observed the
initiation of formation of chamber myocardium [17]. Timothy J N et al studied the treatment of
ESCs improvement in infarcted mice cardiac functions. After ESCs transplantation, the cardiac
tissue functions were improved by 4 week post-infarction, which demonstrated that ESCs
treatment is effective for infarcted myocardial environment [18].

ESCs have potent of differentiation abilities to divide into neural stem cells, which can be utilized
to replace cells in injury brain after stroke. In addition, ESCs are pluripotent stem cells and can
show the beneficial paracrine effect to reduce cells death and support host cells to recover injury
brain [19].

1.2.3 Skeletal Muscle Cells
Skeletal muscle cells have remarkable ability to restore myofiber functions after injury. During the
self-renewing process, skeletal muscle cells not only sustain the stem cell population but also
proliferate and differentiate to provide myogenic cells which proliferate and differentiate to form
new myofiber, which is a highly potential treatment in curing ischemic heart diseases [20].

1.2.4 Induced Pluripotent Stem Cells
Induced pluripotent stem cells (IPSCs) are reprogrammed by adult cells to obtain pluripotent
property like embryonic stem cells with potential to proliferation and differentiation into any cell
types. In ischemic heart disease, IPSCs can contribute to the cell population improvement, tissue
regeneration and tissue function restoration. Compared with ESCs, there is no ethical concern
4

when using IPSCs. Koichi O et al focused on the recovery after stroke by studying neuroepitheliallike stem cells, generated from IPSCs,

and the transplantation to stroke mouse. Quicker

restoration of mouse activities was observed, which proved that transplantation is a promising
method for stroke recovery [21].

1.2.5 Neural Stem Cells
Neural stem cells (NSCs) treatment is one of the promising therapies for the treatment of stroke
and the following damages to the brain [22]. The neural progenitor cells (NPCs) separated from
mouse embryos have the ability to form adult mouse brain neuronal cells [23]. Ishibashi S et al
separated and cultured human NPCs and transplanted the hNPCs into Mongolian gerbils with brain
damage and observed that the neural functions of gerbils with transplantation of hNPCs were
improved significantly, which provided the evidence that hNPCs had highly potential application
in the treatment of human stroke [24].

1.3 Strategies to Enhance Cells Survival under Ischemic
Condition
Stem cells therapy is a promising way for curing ischemic diseases by transplanting stem cells
with the ability of proliferation and differentiation to recover tissue and restore tissue functions.
However, the efficiency of stem cells transplantation remains low. With the low survival rate in
ischemic condition, only a few stem cells can survive and contribute to tissue restoration [25]. To
enhance cells survival in ischemic condition, methods were studied during these years.

Ischemic preconditioning is an effective way to enhance cells survival under ischemic condition.
Ha W K preconditioned MSCs by performing two cycles of ischemia/reoxygenation to stimulate
MSCs gene expression to survive in ischemic condition, which enhanced MSCs survival after
5

engraftment to infarcted heart. Besides, with further studies, increase the number of
preconditioning cycles can more effectively control MSCs survival [26].

Another efficient strategy to enhance cells survival is to increase oxygen level in ischemic tissue
where oxygen is deficient caused by clotting in blood vessels. With sufficient oxygen delivered
to the target tissues, stem cells activities and metabolism are normalized, which is critical to stem
cells proliferation and differentiation to improve tissue restoration.

1.4 Oxygen Release Microspheres Approach
To enhance cells survival in ischemic condition, the delivery of an oxygen releasing system can
provide long-term oxygen supply to support cells biochemical activities. Our laboratory previously
has reported an oxygen release microsphere. The microsphere is core-shell structure with poly
(lactide-co-glycolide) (PLGA) as shell and the complex of H2O2 and poly (2-vinlypyrridione)
(PVP) as core. As PLGA degrades over time, H2O2 is released and decomposed by catalase to
generate oxygen. The oxygen releasing system can provide sustainable oxygen supply and enhance
stem cells survival and differentiation under hypoxic condition for at least two weeks. Cells can
even proliferate after seven-day incubation without massive cell death [27]. To improve the
efficiency of current oxygen therapy, our laboratory invented microspheres focusing on heart
infarction based on the same oxygen release system with properties that the system can be
delivered specifically to the infarcted tissue, which reduced lost by side effects. After the system
is delivered to the infarcted heart, microspheres can gradually release oxygen in sufficient level to
enhance cardiac cell survival and improve differentiation [28].

6

Chapter 2: A pH-sensitive Oxygen Release
Microsphere to Enhance Cells Survival
under Hypoxic Condition in pH=6.5
Condition.
2.1 Introduction
The local pH in ischemic tissues is different from healthy tissues [29-30] The pH difference can
be explained by the complicated pathologies of ischemic disease [31]. While previous reported
oxygen release microspheres cannot control release, many side effects can reduce oxygen release
and weaken cells survival. Copolymerizing pH-sensitive polymer by introducing pH-sensitive
monomers can specify oxygen release system to release excess oxygen only at ischemic tissue,
which reduces influence of side effect and provide sufficient oxygen supply at ischemic tissue.
The pH-sensitive properties were wildly used in drug delivery by conjugation with pH-sensitive
species and it is mature for spreading application in oxygen release [32-39].

2.2 Materials and Methods
2.2.1 Materials Preparation
N-isopropylacrylamide (NIPAAm) was prepared by recrystallizing three times in hexane. 2hydroxyethyl methacrylate (HEMA) and dimethylaminoethyl acrylate (DMAEMA) were purified
by passing through a column with inhibitor removers. Chain transfer agent was dissolved in
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dioxane with concentration of 0.0403g/0.3mL. Azobisisobutyronitrile (AIBN) was dissolved in
dioxane with concentration of 0.0032g/0.2mL.

2.2.2 Monomers Synthesis
Acrylate poly lactide (APLA) was synthesized by a two-step reaction. Firstly, polylactide (HOPLA-OCH3) was synthesized by NaOCH3-initiated ring-opening polymerization of lactide.
Lactide (3,6-Dimethyl-1,4-dioxane-2,5-dione,100g,0.694mol) was dissolved in 150mL of
dichloromethane (DCM). 0.037mol NaOCH3 was dissolved in 0.494 mol methanol with the
concentration of 2g/20mL. NaOCH3 solution was added dropwise in lactide solution under
vigorous stirring. The flask was surrounded by ice to maintain 0°C for 2h. After reaction, the
solution was sequentially rinsed with 0.1M HCl and deionized (DI) water. The bottom organic
layer was isolated and dried over with anhydrous MgSO4. The solvent was removed by blowing
air drying in hood and finally obtain HO-PLA-OCH3 about 90g. Secondly, acryloyl chloride
(38mL, 0.4mol) was added dropwise into the solution with 150 mL dichloromethane solvent
containing 90g, 0.39mol HO-PLA-OCH3 and 65mL,0.47mol triethylamine. The reaction was
processed at 0°C overnight. After reaction, precipitates in the solution were removed by filtration
and the solution was then rinsed sequentially with 0.2M Na2CO3, 0.1M HCl and saturated NaCl
solution. The bottom organic layer was isolated and dried over with anhydrous MgSO4. The
solvent dichloromethane was then removed by blowing air dry in the hood to get the raw product
of APLA, which was finally purified by flash chromatography (EA/Hexane,2/1) and the final yield
was about 60%. The structure of APLA monomers were confirm by 1H-NMR.

N-Acryloxysuccinimide (NAS) was synthesized by first dissolving 115g N-Hydroxysuccinimide
(NHS) and 110g trimethylamine in 1500mL chloroform at 0°C. Then 100g acryloyl chloride was
8

added dropwise over a 20-minutes period under vigorous stirring. The reaction was continued for
another 20 min after the acyloyl chloride was added. Then the solution was washed with 800mL
ice cold water and saturated brine and dried with anhydrous MgSO4. The solvent was evaporated
to yield a white solid. The chemical structure of NAS was confirmed by 1H-NMR.

2.2.3 Polymer Synthesis
The polymer was synthesized by reversible addition fragmentation chain-transfer (RAFT)
polymerization method. NIPAAm, HEMA, NAS, APLA and DMAEMA were copolymerized with
three feeding ratios of 50/5/20/20/5, 45/5/20/20/10 and 40/5/20/20/15. Monomers were
sequentially dissolved in 5.5mL dioxane. After solids were fully dissolved, nitrogen was purged
for 20 minutes to remove oxygen from reaction environment. Then 0.3mL CTA solution was
added as RAFT agent in solution under nitrogen aerating. After another 10 minutes aerating
nitrogen, AIBN was added as the initiator. The reaction was kept in 70°C oil bath with nitrogen
protection and magnetic stirring for 48 hours. The polymer was precipitated out in cold hexane,
then separated from hexane by filter and purified twice by dissolving in dioxane and precipitating
in hexane. Finally, the product was vacuum dried for 24 hours to remove solvent before use. The
structure of the polymer and actual ratio of components were confirmed by 1H-NMR.

2.2.4 Hydrogel Synthesis
The APLA hydrogel was synthesized by free radical polymerization as previously reported [28].
Monomers NIPAAm, HEMA and APLA were copolymerized with a molar feeding ratio of
86/10/4. Benzoyl peroxide (BPO) solution was prepared by dissolving BPO solid in dioxane at
concentration of 10mg/mL. NIPPAAm, HEMA and APLA were dissolved in dioxane in a 250mL
three-neck round bottom flask. After purging nitrogen for 20 minutes to remove oxygen from
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reaction environment, the initiator was added and the flast was placed in 70°C oil bath overnight
with nitrogen protection. The polymer was precipitated out by pouring the solution into hexane.
Solid polymer was collected with filter and continued purification twice by dissolving polymer in
tetrahydrofuran (THF) and precipitating in ethyl ether. The APLA gel polymer was vacuum dried
overnight before use. The structure and ratio of components were confirmed by 1H-NMR.

2.2.5 Polymer Properties Characterization
In order to test degradation rate of synthesized polymers in different pH environment, the polymer
was firstly dissolved in dichloromethane at a concentration of 60 mg/1Ml and uniformly separated
into 1.5mL microcentrifuge tubes (0.2mL solution per tube), then placed in hood for evaporating
solvent by air blow dry for 24 hours. Phosphate buffer saline (PBS) with pH=6.5 was prepared by
adding 0.1M HCl in PBS solution and confirmed by a pH meter (PBS original pH is 7.4). 200 µL
of PBS solution with pH=6.5 and pH=7.4 was added to each tube after the dichloromethane was
fully evaporated. The tubes were placed in 37°C water bath to form hydrogel. The degradation
was conducted for 4 weeks at 37°C. At the time point day 1, 7, 14, 21 and 28, the supernatant was
removed and the weight of the hydrogel was measured as wet weight (w1). After freeze drying,
the weight of the hydrogel was measured as dry weight (w2). The water content was calculated as:

Water Content (%) = (w1-w2)/w1×100%

The polymer weight before adding phosphate buffer saline was measure as original weight (w3).
To determine polymer degradation rate weight remaining was calculated as:

Weight Remaining (%) = w2/w3×100%

10

6 repeats were used in each measurement.

The degradation product cytotoxicity was tested with MTT assay using medium obtained from
degradation rate experiment at day 21 when the degradation product was totally dissolved in
phosphate buffer saline solution. For culturing cells for MTT assay, rat cardiac fibroblasts (RCFs)
were cultured in minimum essential medium (MEM) containing 10% fetal bovine serum and 1%
penicillin 37°C, 5% CO2 incubator. Culture media was changed every other day. After cells
confluence reached 90%, cells were passaged by removing medium and adding prewarmed trypsin
and PBS, placing in incubator for 5 minutes to detach cells from the bottom. Culture medium was
added in solution to dilute trypsin concentration for protecting cells from trypsin’s toxicity.
Solution was transferred into 50mL centrifuge tube and centrifuged at the speed of 1600 round per
minutes for 7 minutes. The supernatant was removed and cells were suspended in fresh medium.
Cells number was calculated using a hemocytometer under optical microscope observation. Cells
were seeded in 96 wells plate with each well containing 0.2mL culture medium and 2×104 cells,
then incubated for 24 hours followed by medium change. The degradation product solution in
culture medium with the concentration of 0.01mL/0.2mL was prepared added to the well. After
48-hour incubation, 0.02mL 5mg/mL MTT solution was added to each well to incubate for 4 hours.
After that, the medium was carefully removed and 0.2mL DMSO was added to each well then
shaken until solids at wells bottom were fully dissolved. The absorbance at 560 nm was read by a
plate reader and subtracted background at 670nm.

2.2.6 Oxygen Release Microspheres Fabrication
The oxygen release microspheres (ORM) based on core-shell structure with synthesized polymer
as shell and polyvinylpyrrolidone-hydrogen peroxide complex (PVP/H2O2) as core were fabricated
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by double emulsion. PVP/H2O2 complex was prepared by mixing 2.42g PVP in 10mL H2O2 (30%),
then stirred at 4°C overnight. Polyvinyl alcohol (PVA) solution was prepared by dissolving PVA
at a concentration of 2g/50mL. 0.2mL PVP/H2O2 was added into polymer solution that is prepared
by dissolving 200mg polymer in 4mL DCM. With separate two layers of two phases of liquid
initially, the mixture was sonicated by a ultrasound sonicator for 1 minutes in 30% to form double
emulsion. The first emulsion was poured rapidly into 50mL PVA solution for stirring for 4 minutes
with speed of 600 rpm. Transferred suspended liquid into 450mL DI water under stirring for 2.5
hours to wash and evaporate out of solvent. Centrifuged for 4 times at speed of 12000 rpm for 15
minutes to collect raw products of microspheres. Before conjugation with catalase, microspheres
were freeze dried for accurately measuring weight. The morphology and size of microspheres were

2.2.7 Catalase Conjugation
To conjugate microspheres with catalase, added 50mg microspheres into 6mL 6mg/mL catalase at
4°C under stirring for 4 hours, then centrifuged twice at speed of 12000 rpm for 15 minutes to
collect catalase conjugation microspheres. The structure of microspheres was confirmed by
staining catalase with FITC. The method is mixing 0.025mL 100× FITC solution that is prepared
by adding 4mg FITC into 1mL 100mM Na2CO3 with 1mL 10mg/mL catalase for 2 hours, then
dialysis in DI water at 4°C for 24 hours. The catalase could be observed by confocal image, which
confirmed the structure of microspheres and conjugation of catalase.

2.2.8 Oxygen Release Kinetics
The microspheres conjugated with catalase were fabricated as described. To test difference of
oxygen release rate between pH=6.5 and pH=7.4 environment, sustained oxygen release under
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acid and alkaline PBS was conducted for 28 days by detecting intensity of oxygen sensitive
fluorescent. To fabricate oxygen sensitive membrane, mixed Ru(Ph2phen3)Cl2 (7mg) that is
oxygen sensitive luminophore and rhodamine-B (5mg) that is oxygen-insensitive fluorophore with
polydimethylsiloxane (PDMS) (10g). Fully mixed them then added 1g curing agent. After
transferring to 100mm petri dish and incubating at 50°C for half an hour, the highly oxygen
permeable and hydrophobic PDMS membrane was collected. The membrane was stored at 4°C
covered by tinfoil for lightless environment. The membrane was cut to disks of 6mm diameter that
is suitable for wells size of 96-well black microplate and placed at the bottom of each well.
Prepared pH=6.5 and pH=7.4 PBS as described, then mixed microspheres with acid and alkaline
PBS at 4°C until solid microspheres were fully suspending. Added 0.2mL mixture to each well
and placed in 37°C, 5% CO2, 1% O2 incubator for 2 hours to balance the oxygen content, then
quickly sealed the plate with transparent film (Thermal®Seal films classic, polypropylene, Sigma).
The oxygen release conducted for 28 days at 1% O2 incubator and the plate was read at every day
in first week and every two days in the last three weeks. The plate was read by fluorescent plate
reader, which for Ru(Ph2phen3)Cl2 is 610nm with 470nm excitation and for rhodamine-B is 576nm
with 543nm excitation. The repeating number in each group was 8 and experiment repeating was
1 time.

2.2.9 Mesenchymal Stem Cells Culture
Mesenchymal stem cells (MSC) were cultured in Dulbecco's modified eagle medium (DMEM)
containing 10% fetal bovine serum (FBS) and 1% penicillin. The MSC were incubated in 5%
CO2 and 21% O2 at 37°C. The medium was changed every two days and cells were passaged
when reached 90% confluences. The cells used in survival experiment were at passages 18 and
19 while cells remain multipotency.
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2.2.10 Encapsulated Mesenchymal Stem Cells and Oxygen Release
Microspheres into Hydrogel
The hydrogel was APLA gel that was synthesized as described. The APLA gel powder, PBS
solvent and oxygen release microspheres were sterilized under UV for around an hour before use.
APLA gel powder was dissolved in PBS at a concentration of 60mg/mL with stirring at 4°C
overnight. Microspheres conjugated with catalase were added into hydrogel solution at a
concentration of 40mg/mL. Mesenchymal stem cells (MSC) suspended medium was mixed with
hydrogel solution at a concentration of cells number of 4 million/mL. 1mL syringes were precooled at -20°C to use to mix them thoroughly. All these procedures were operated on ice in
sterility.

2.2.11 Creation of Different pH Condition
The method of changing microspheres oxygen releasing environment is adjusting pH of incubation
medium. The mesenchymal stem cells (MSC) were cultured by Dulbecco's modified eagle medium
(DMEM). The normal DMEM contained sodium bicarbonate buffer used as pH buffer to sustain
pH at 7.4, which hindered the pH adjusted to 6.5. To remove the influence of sodium bicarbonate
buffer, DMEM powder without pH buffer was chosen. DMEM powder was dissolved into 1L
sterile DI water and pH of solution was changed from 3.3 to 6.5 by adding 1M NaOH at a
concentration of 12

NaOH solution/5mL medium.

2.2.12 Mesenchymal Stem Cells Survival under Ischemic Condition in
Hydrogel Loaded with Oxygen Release Microspheres
To test cells survival under both pH=6.5 and pH=7.4 environment, cells were incubated with
culture medium at pH6.5 and 7.4. The hydrogel mixture was separated to 0.2mL each 1.5mL
microcentrifuge tube, while tubes were prepared by punching a hole on the top. The tubes were
incubated in 5% CO2, 21% O2, 37°C incubator for 24 hours at first. Then medium of pH=7.4
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groups tubes was replaced with normal DMEM (pH=7.4) that did not contain FBS and medium of
pH=6.5 groups tubes was replaced with pH=6.5 DMEM without FBS. All the groups were
incubated in hypoxia incubator with 1% O2 and 5% CO2 at 37°C for 14 days, which simulated
ischemic condition in different pH microenvironment. Medium was replaced every two days.
Papain solution was prepared by mixing 48.6mL PBS with 625
L-Cystein stock solution (242mg/10mL DI water) and 300

papain stock solution, 500
EDTA stock solution. After 1, 7

and 14 days of incubation, the gels were digested by papain solution. To quantify cells survival,
dsDNA assay that was for live cells was used and measured by a Quant-iT™ PicoGreen.

2.2.13 Statistical Analysis
All results were presented as mean ±standard deviation. The significant difference between
experimental groups were analyzed using one-way ANOVA, and the significant difference was
determined by p-value<0.05.

2.3 Results
2.3.1 Synthesis of pH-sensitive Degradable Polymer
The biodegradable APLA hydrogel was synthesized by free radical polymerization. (Figure 1) The
structure of APLA hydrogel was confirmed by 1H-NMR. (Figure 2) The pH-sensitive polymer was
synthesized by copolymerization of NIPAAm, HEMA, NAS, APLA and DMAEMA using RAFT
with three different feed ratios of 50/5/20/20/5, 45/5/20/20/10 and 40/5/20/20/15. (Figure 3) The
actual components ratio and the structure of the hydrogel and the polymer was confirmed by 1HNMR. (Figure 4, 5, 6) The mole ratio of NIPAAm/NAS/APLA/NAS/DMAEMA was consistent
with the feed ratio. (Table 1, 2, 3)

15

2.3.2 Characterization of pH-sensitive Degradable Polymer
The water content illustrated the ability of polymer absorbing water in different pH condition.
With the component DMAEMA, after incubation in pH=6.5 and pH=7.4 PBS for 24 hours, the
pH-sensitive polymer had different water content. (Figure 7, 8, 9) In the three kinds of polymer,
the water contents were all higher in pH=6.5 condition than in pH=7.4 condition. For the polymer
with DMAEMA mole ratio of 5%, its water content was 45.63%+ 6.72% in pH=6.5 condition and
38.14%+ 3.49% in pH=7.4 condition. The p value calculated by ANOVA was 0.036<0.05, which
meant the two group have significant difference. For the polymer with DMAEMA mole ratio of
10%, its water content was 53.53%+ 0.78 in pH=6.5 condition and 50.14%+ 1.26% in pH=7.4
condition. The p value calculated by ANOVA was 0.0016<0.005, which meant the two group have
significant difference. For the polymer with DMAEMA mole ratio of 15%, its water content was
61.53%+ 4.09% in pH=6.5 condition and 56.50%+ 1.14% in pH=7.4 condition. The p value
calculated by ANOVA was 0.016<0.05, which meant the two group have significant difference.

The degradation rate of the pH-sensitive polymer was characterized by incubation of polymer in
pH=6.5 and pH=7.4 PBS for 3 weeks. Took out sample at time point of day 7, 14, 21 and 28 and
the weight remain of polymer was measured by the ratio of dried weight of samples to the original
weight of polymer. (Figure 10, 11, 12) As the figures showed, in all the tree kinds of polymer
degradation, polymer degraded faster in the condition of pH=6.5 than that in the condition of
pH=7.4. For the polymer with DMAEMA mole ratio of 5%, the weight remaining in pH=6.5
condition was 63.02% ± 4.64% and in pH=7.4 condition was 69.45% ± 5.11%. For the polymer
with DMAEMA mole ratio of 10%, the weight remaining in pH=6.5 condition was 59.25% ±4.80%
and in pH=7.4 condition was 74.62% ± 6.40%. For the polymer with DMAEMA mole ratio of
15%, the weight remaining in pH=6.5 condition was 62.11% ± 4.64% and in pH=7.4 condition
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was 72.39% ±2.13%. The p value of the two groups was 0.0061, which meant they have significant
difference.

The toxicity of polymer degradation product was tested by MTT assay. Collected medium from
polymer degradation experiment where the degradation product was dissolved in the medium.
Cultured RCF under the medium mixed with the collected medium at a concentration of
10mL/200mL for a day and did the MTT assay. (Figure 13) The cells viability of degradation
product of the polymer with 5% and 10% mole ratio of DMAEMA was 95.93% and 88.95% while
control group is 100%. There is no significant difference between the three groups.

2.3.3 Fabrication of pH-sensitive Oxygen Release Microspheres
The microspheres were fabricated by the method of double emulsion to form core-shell structure
with pH-sensitive polymer as shell and PVP/H2O2 complex as core. (Figure 14) By staining
catalase with FITC and conjugating with microspheres on the shell, the conjugation of catalase
was confirmed by the confocal image. (Figure 15)

2.3.4 Characterization of pH-sensitive Oxygen Release Microspheres
The oxygen releasing rate in different pH condition was tested by incubation of catalase conjugated
oxygen release microspheres in pH=6.5 and pH=7.4 PBS in hypoxia incubator (37oC, 1% O2, 5%
CO2) for 4 weeks and read the fluorescent intensity of oxygen by placing oxygen-sensitive
fluorescent membrane on wells bottom. (Figure 16) While under pH=6.5 condition, there is higher
oxygen fluorescent intensity. At the beginning of incubation, both groups had similarity in oxygen
fluorescent intensity. While after day 4, the fluorescent intensity of pH=6.5 groups surpassed the
pH=7.4 group and reached to highest oxygen fluorescent intensity at day 11, which represented
highest oxygen level in incubating well.
17

At the beginning of the oxygen release, the p value of the pH=6.5 and pH=7.4 groups at day 3 and
4 were 0.13 and 0.77, which represented that they did not have significant difference (p value<
0.05) so the oxygen level in two groups were same at the beginning. At day 6, 7, 9, 11 and 14, the
p value of two groups were 0.000043, 0.00002, 0.000069, 0.00035 and 0.002, which meant in this
time period of oxygen release, the oxygen level in the two groups had significant difference and
pH=6.5 group had higher oxygen level. At day 21 and 26, the p value of two groups were 0.33 and
0.0011, which meant at day 21, the oxygen level in two groups did not have significant difference
but while the oxygen release was conducted to day 26, there was significant difference between
two groups.

2.3.5 Cell Survival under Ischemic Condition with pH-sensitive Oxygen
Release Microspheres
Cell survival with pH-sensitive oxygen release microspheres was conducted by incubation of cells
and microspheres encapsulated in APLA hydrogel in hypoxia incubator (37oC, 1% O2, 5% CO2)
under different pH=6.5 and pH=7.4 cells culture medium for 14 days. The amount of live cells
was characterized by dsDNA content measured by Picogreen dsDNA Assay at the time point of
day 0, 7 and 14. (Figure 17 and 18) In gel only group, less than 50% of the cells died after 14 days.
With oxygen release microspheres added during hypoxic incubation, cells population did not
decrease but increased a lot. The ratio of dsDNA content in APLA gel/oxygen release
microspheres to that in APLA gel group in pH=6.5 condition is 3.86, which is higher than that in
pH=7.4 condition that is 3.40.

As for group DMAEMA-5 (Figure 19), the dsDNA content showed that the oxygen release
microspheres can enhance cell survival in both pH condition at day 7 with significant difference
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between APLA Gel group and microspheres group. However, after removing the pH influence to
cell survival by calculating ratio of microspheres group and gel group, in pH=6.5 condition, the
ratio is 2.67 that is higher than the ratio that is 1.61 in pH=7.4 condition, which meant the oxygen
release microspheres had stronger effort of cell survival enhancement in pH=6.5 condition. At day
14, in pH=6.5 condition, the microspheres group had significant difference with gel group, while
in pH=7.4, there was no significant difference. The oxygen release microspheres could enhance
more cell survival in pH=6.5 condition. As for group DMAEMA-15 (Figure 20), by calculating
the ratio of microspheres group and gel group at day7, the ratio is 2.03 in pH=6.5 condition while
in pH=7.4 condition, the ratio is 1.71. With the higher ratio, the microspheres had stronger effort
of cell survival improvement in pH=6.5 condition.

Figure 1 Synthesis scheme of APLA hydrogel
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Figure 2 1H-NMR spectrum of APLA hydrogel

Figure 3 Synthesis scheme of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA
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Table 1 Feed ratio and real ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-coDMAEMA (DMAEMA-5)
NIPAAm

HEMA

NAS

APLA

DMAEMA

Feed Ratio

50

5

20

20

5

Real Ratio

51

4

19

19

7

Table 2 Feed ratio and real ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-coDMAEMA (DMAEMA-10)
NIPAAm

HEMA

NAS

APLA

DMAEMA

Feed Ratio

45

5

20

20

10

Real Ratio

46

5

18

20

11

Table 3 Feed ratio and real ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-coDMAEMA (DMAEMA-15)
NIPAAm

HEMA

NAS

APLA

DMAEMA

Feed Ratio

40

5

20

20

15

Real Ratio

38

7

18

20

17

21

Figure 4 1H-NMR spectrum of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA
(DMAEMA-5)
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Figure 5 1H-NMR spectrum of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA
(DMAEMA-10)

Figure 6 1H-NMR spectrum of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA
(DMAEMA-15)
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Figure 7 Water content of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA
(DMAEMA-5) in different pH condition
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Figure 8 Water content of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA
(DMAEMA-10) in different pH condition
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Figure 9 Water content of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA
(DMAEMA-15) in different pH condition
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Figure 10 Weight remain during degradation of polymer NIPAAm-co-HEMA-co-NAS-co-APLAco-DMAEMA (DMAEMA-5) in different pH condition
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Figure 11 Weight remain during degradation of polymer NIPAAm-co-HEMA-co-NAS-co-APLAco-DMAEMA (DMAEMA-10) in different pH condition
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Figure 12 Weight remain during degradation of polymer NIPAAm-co-HEMA-co-NAS-co-APLAco-DMAEMA (DMAEMA-15) in different pH condition
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Figure 13 Cells viability of degradation product of polymer NIPAAm-co-HEMA-co-NAS-coAPLA-co-DMAEMA (DMAEMA-15) and polymer NIPAAm-co-HEMA-co-NAS-co-APLA-coDMAEMA (DMAEMA-10)
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Figure 14 SEM image of fabricated microspheres

Figure 15 Confocal image of microspheres conjugated with catalase stained by FITC
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Figure 16 Oxygen fluorescent intensity of wells incubating the oxygen release microspheres with
the shell of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA (DMAEMA-5)
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Figure 17 dsDNA content of MSCs culture in APLA gel and APLA gel/oxygen release
microspheres (polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA (DMAEMA-10) as
shell) in hypoxic incubator and pH=6.5 condition for 14 days.
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Figure 18 dsDNA content of MSCs culture in APLA gel and APLA gel/oxygen release
microspheres (polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA (DMAEMA-10) as
shell) in hypoxic incubator and pH=7.4 condition for 14 days.
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Figure 19 dsDNA content of MSCs culture in APLA gel and APLA gel/oxygen release
microspheres (polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA (DMAEMA-5) as
shell) in hypoxic incubator and in pH=7.4 and pH=6.5 conditions for 14 days.
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Figure 20 dsDNA content of MSCs culture in APLA gel and APLA gel/oxygen release
microspheres (polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-DMAEMA (DMAEMA-15) as
shell) in hypoxic incubator and in pH=7.4 and pH=6.5 conditions for 14 days.

2.4 Discussion
The 1H-NMR spectrum showed that all the monomers were copolymerized and their character
peak could be found in the spectrum. NIPAAm was responsible to thermal-sensitive property.
HEMA increased hydrophilicity. APLA was degradable monomer. NAS was used to conjugate
with catalase via NHS-amine reaction. DMAEMA was the pH-sensitive domain. For the reason
that the amine groups on DMAEMA were more reactive in pH=6.5 condition by combine with
hydrogen ion, the hydrophilic of the polymer was increased and absorbed more water in gelation.
With the higher water content in pH=6.5, the gel can degrade faster than that in condition of
pH=7.4 by more effective hydrolysis. With the higher rate of degradation, the oxygen release
microspheres that used pH-sensitive polymer as shell structure can release more H2O2 during the
faster degradation of polymer. The H2O2 was decomposed by the catalase conjugated on
microspheres shell and released oxygen. From the higher fluorescent intensity in pH=6.5 groups,
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there was more oxygen in wells, which illustrated that microspheres under pH=6.5 condition can
release more oxygen. With more oxygen releasing, more cells can survive and proliferate, which
caused the dsDNA content increased. While MSCs were normally incubated in pH=7.4 medium
with pH buffer to sustain, incubated MSCs in pH=6.5 condition would naturally decrease the cells
survival that represented in dsDNA content decreasing. With the natural reduction of cells survival,
directly comparing two groups dsDNA content was not rational. To weaken the effect of natural
reduction, compared two groups the ratio of the dsDNA content of APLA gel group to APLA
gel/oxygen release microspheres group, where the ratio in pH=6.5 condition was 3.86 and the other
is 3.40. The higher ratio illustrated that in the group of under condition of pH=6.5, oxygen
microspheres can release more oxygen to improve MSCs survival and proliferation to more cell
population. The APLA gel still exist after dsDNA assay, which can provide mechanical and
structural support to oxygen release microspheres and MSCs in application therapy. The SEM
image confirmed that the diameter of microspheres is 2injection. The MTT assay demonstrated that the degradation product of polymer was not toxicity
to cells because there is no significant difference occurring between the cell viability of control
group and experiment group.

2.5 Conclusion
With the pH-sensitive polymer as shell, oxygen release microspheres can be tailored to release
more oxygen under low pH condition. While in application, ischemic diseases like brain stroke
will cause a pH gradient in the tissue where the damaged tissues have lower pH condition. The
treatment of injecting MSCs into ischemic tissue will make MSCs into harsh survival environment.
The pH-sensitive oxygen release microspheres with APLA gel can enhance MSCs survival by
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releasing more oxygen, sustaining oxygen concentration in ischemic condition and providing
mechanical support, which improve MSCs proliferation and increase efficiency of MSCs therapy.
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Chapter 3: A pH-sensitive Oxygen Release
Microsphere to Enhance Cells Survival
under Hypoxic Condition in pH=7.4
Condition.
3.1 Introduction
Because in ischemic condition, tissue will present different pH compared with normal tissue,
which is interesting to discover and invent various pH-sensitive therapeutic strategies to enhance
efficiency [40-42]. With the introduction of pH-sensitive monomers in the copolymer to obtain
pH-sensitive property, the oxygen release system can be more efficient in that it releases more
oxygen at ischemic tissue but less oxygen in healthy tissue. The pH-sensitive properties are
impressive and in diverse applications, pH-sensitive species have been introduced to specialize
utilization and improve efficiency. Especially in drug delivery system, pH-sensitive
specialization has attracted much attention [43-50].

3.2 Materials and Methods
3.2.1 Materials Preparation
The monomers NIPAAm was prepared by recrystallized in hexane for three times and freeze
dried before use. HEMA was dropped to pass through cylinder full of inhibitor remover for
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preparation. APLA, NAS were synthesized as described in Chapter 2.2.2. The initiator BPO were
prepared by dissolving in dioxane at a concentration of 10mg/mL.

3.2.2 Synthesis of PAA
50g of diethyl propylmalonate was mixed with 350mL of 1mol/L KOH and a 95% ethanol solution
overnight under stirring. Rotary evaporator was used to condense the mixture and added
hydrochloric acid into the yellowish oil to adjust the solution pH to 1.5-2.0. To extract crude
product, added 600mL ethyl ether into solution. After extraction, ether layer was dried out by
magnesium sulfate overnight and filtered. Excess ether was removed by a rotary evaporator. Then
the product was mixed with 27.5mL diethylamine at 0°C thoroughly. 21.8mL of a formaldehyde
solution was slowly added into the mixture and stirred overnight. Then the mixture was heated to
60°C under stirring and stirred for additional 12 hours. Sulfuric acid was added and the mixture
was cooled down to 0°C, then the product was extracted with ether and crude ethyl 2propylacrylate was obtained. The crude product was hydrolyzed by 1 mol/L KOH and refluxed at
60°C. pH was adjusted to 1.5-2.0 by adding hydrochloric acid. Separated and extracted product by
adding diethyl ether and used rotary evaporator to remove ether from the final product. The
structure of PAA was confirmed by 1H-NMR.

3.2.3 Polymer Synthesis
Monomers

APLA

and

NAS

were

synthesized

as

described.

Polymer

NIPAAm/HEMA/NAS/APLA/PAA was synthesized by free radical method at three feeding mole
ratios of 50/5/20/20/5, 45/5/20/20/10 and 40/5/20/20/15 separately. Monomers weight was
measured and monomers were dissolved in dioxane at a 250mL three-neck round bottom flask
with that the ratio of weight of all the monomers over the volume of solvent was 1g/40mL.
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Nitrogen was purged to remove oxygen from reaction environment for 20 minutes and BPO was
added into dioxane solution as initiator then continued purging nitrogen for additional 20 minutes.
Placed flask in 70°C oil bath with stirring for reacting overnight under nitrogen protection. To
harvest polymer, solution was poured in hexane that was pre-cooled in -20°C. The polymer was
precipitated from hexane and collected by vacuum filtered. To purify the polymer, dissolved the
polymer in THF and precipitated in anhydrous ethyl ether twice. The purified polymer was
collected by vacuum filtered and vacuum dried. The polymer was freeze dried before use and
characterization. The structure of the polymer and actual mole ratio of components were confirmed
by 1H-NMR.

3.2.4 Polymer Characterization
The water content of polymer was measure at time point of day 1 and 7. The polymer was gelated
in pH=6.5 and pH=7.4 PBS and degraded for 21 days. The MTT assay of polymer degradation
product was proceeded using medium collected from degraded polymer where the degradation
product was dissolved in medium.

3.2.5 Oxygen Release Microspheres Fabrication and Catalase Conjugation
Fabricated microspheres by the method of double emulsion and conjugated with catalase by
stirring at 4oC for 4 hours. The microspheres were freeze dried before use. The size of microspheres
was confirmed by SEM image.

3.2.6 Microspheres Oxygen Release
The microspheres were incubated in pH=6.5 and pH=7.4 PBS in hypoxic incubator for 20 days.
Read oxygen fluorescent every day in the first week and every two days in the last few weeks. The
repeating number in each group is 8 and experiment repeating was 2 times.
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3.2.7 Cells Survival with Oxygen Releasing Microspheres in Hypoxic and
Different pH Condition
Cells suspending medium was mixed with APLA solution that was prepared by stirring at 4oC
overnight and oxygen release microspheres together under ice surrounded temperature protection.
The mixture was separated to 0.2 mL in each 1.5 mL tube that is prepared by punching a hole on
its top. Incubating cells in hypoxic incubator in pH=6.5 and pH=7.4 culture medium for 14 days.
At time point day 0, 7 and 14, took out tubes and added papain digest solution. The tubes were
incubated at 60oC overnight and used dsDNA assay that was for live cells and measured by a
Quant-iT™ PicoGreen.

3.2.8 Statistical Analysis
All results were presented as mean ±standard deviation. The significant difference between
experimental groups were analyzed using one-way ANOVA, and the significant difference was
determined by p-value<0.05.

3.3 Results
3.3.1 Synthesis of pH-sensitive Polymer
The polymer was synthesized by the method of free radical. (Figure 21) The structure and the
real ratio of components (Table 4, 5, 6) were confirmed by 1H-NMR. (Figure 22, 23, 24)

3.3.2 pH-sensitive Polymer Characterization
The polymer was incubated in pH=6.5 and pH=7.4 PBS for gelation and degradation. The water
content was calculated at day 1 and 7. (Figure 25, 26) There was no significant difference under
pH=6.5 and pH=7.4 in three groups water content in day 1. In day 7, all the three groups appeared
higher water content under pH=7.4 than that in pH=6.5 and the water content of polymer with 10%
and 15% mole ratio of PAA had significant difference between pH=6.5 and pH=7.4 condition.
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And the water content of polymer with 5% mole ratio of PAA had significant difference between
two pH groups at day 14. (Figure 30) At day 7, the water content of polymer with 10% ratio of
PAA was 39.53% +6.90% at pH=6.5 and was 57.05% +6.19% at pH=7.4 while the p value between
the water content in two pH condition is 0.00093<0.005, which meant they had significant
difference. At day 7, the water content of polymer with 15% ratio of PAA was 49.97% +4.17% at
pH=6.5 and was 57.96% +4.03% at pH=7.4 while the p value between the water content in two
pH condition is 0.0071<0.05, which meant they had significant difference.

The degradation of polymer was conducted for 21 days. (Figure 27, 28, 29) For polymer with 5%
mole ratio of PAA, at day 21, its weight remaining was 88.99% ±5.25% in pH=6.5 group and was
68.08% ±4.83% in pH=7.4 group while the p value of weight remaining of different pH group was
0.0071<0.05, which meant that they had significant difference. For polymer with 10% mole ratio
of PAA, at day 28, its weight remaining was 92.11% ±2.72% in pH=6.5 group and was 80.25% ±
3.09% in pH=7.4 group while the p value of weight remaining of different pH group was
0.0033<0.005, which meant that they had significant difference. For polymer with 15% mole ratio
of PAA, at day 21, its weight remaining was 86.72% ±4.53% in pH=6.5 group and was 77.29% ±
3.44% in pH=7.4 group.

The toxicity of polymer degradation product was tested by MTT assay. Collected medium from
polymer degradation experiment where the degradation product was dissolved in the medium.
Cultured RCF under the medium mixed with the collected medium at a concentration of
10mL/200mL for a day and did the MTT assay. (Figure 31) The cells viability of degradation
product of the polymer with 10% and 15% mole ratio of PAA was 104.28% and 101.93% while
control group is 100%. There is no significant difference between the three groups.
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3.3.3 Microspheres Fabrication and Characterization
The pH-sensitive oxygen release microspheres were synthesized by the method of double emulsion
and conjugated with catalase by stirring at 4oC for 4 hours. The size of microspheres was confirmed
by SEM image. (Figure 32)

3.3.4 Microspheres Oxygen Releasing Rate
By incubating pH-sensitive oxygen release microspheres in hypoxic incubator and PBS of
different pH for 20 days, the curve showed that the wells incubating microspheres with polymer
NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA as shell structure in pH=7.4 PBS always have
higher oxygen fluorescent intensity than that groups in pH=6.5 PBS. From the beginning of
incubation, the oxygen fluorescent intensity in pH=7.4 group was higher than that in pH=6.5 group
and reached to the peak at day 7, which represented that the oxygen level in incubating wells was
highest at day 7.

For the microsphere that shell structure polymer had 5% molar ratio of PAA (PAA-5), at day 5
and 7, the p value of two groups pH=6.5 and pH=7.4 were 0.00042 and 0.000099, which
represented the significant difference (p value< 0.05) between the two groups and pH=7.4 group
had higher oxygen level. While the oxygen release was conducted to day 15, the p value of two
groups was 0.40, which meant there was no significant difference between the two groups and the
oxygen level was same in two groups. For the microsphere that shell structure polymer had 10%
molar ratio of PAA (PAA-10), at day 5, 7, 9, 11, 15, 17 and 19, the p value of pH=6.5 and pH=7.4
groups were 0.0072, 0.024, 0.0062, 0.0038, 0.0022, 0.0014 and 0.0026, which meant there was
significant difference between the two groups in all these time point. The PAA-10 microspheres
can release oxygen faster in pH=7.4 condition with higher oxygen level during the oxygen release
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conducting. For the microsphere that shell structure polymer had 15% molar ratio of PAA (PAA15), at day 7 and 9, the p value of the pH=6.5 and pH=7.4 groups were 0.13 and 0.26, which meant
there was no significant difference between the two groups. However, when the oxygen release
was conducted to day 15, 17 and 19, the p value of the two groups were 0.067, 0.047 and 0.048,
which meant there was significant difference between the two groups at day 17 and 19 and pH=6.5
group had higher oxygen level.

3.3.5 Cells Survival with Oxygen Releasing Microspheres in Hypoxic and
Different pH Condition
The Figure 36 showed the normalized dsDNA content of the oxygen release microspheres group
and APLA gel group in both pH=6.5 and pH=7.4 condition at day 0, 7 and 14. All the microspheres
groups had significant difference to the gel group at the same time point and pH condition. To
compare the effort of the enhancement of cell survival in different pH condition, calculated the
dsDNA content ratio of microspheres group and gel group. At day 7, the ratio in pH=6.5 condition
is 2.37 that was little lower than the ratio that was 2.39 in pH=7.4 condition, but at day 14, the
ratio in pH=6.5 was 1.93 while the ratio in pH=7.4 was 2.23. The higher ratio meant the stronger
effort of cell survival improvement so the microspheres can enhance more cell survival in pH=7.4
condition.
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Figure 21 Synthesis scheme of NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA

Table 4 Feed ratio and real ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA
(PAA-5)
NIPAAm

HEMA

NAS

APLA

PAA

Feed Ratio

50

5

20

20

5

Real Ratio

50

6

16

20

8
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Table 5 Feed ratio and real ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA
(PAA-10)
NIPAAm

HEMA

NAS

APLA

PAA

Feed Ratio

45

5

20

20

10

Real Ratio

47

6

17

19

11

Table 6 Feed ratio and real ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA
(PAA-15)
NIPAAm

HEMA

NAS

APLA

PAA

Feed Ratio

40

5

20

20

15

Real Ratio

41

5

17

18

19

Figure 22 1H-NMR spectrum of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-5)
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Figure 23 1H-NMR spectrum of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA10)
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Figure 24 1H-NMR spectrum of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA15)
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Figure 25 Water content of three ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA
(PAA-5, 10 and 15) at day 1
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Figure 26 Water content of three ratio of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA
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Figure 27 Degradation of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-5) for
21 days
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Figure 28 Degradation of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-10) for
28 days
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Figure 29 Degradation of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-15) for
21 days
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Figure 30 Water content of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-5) at
day 14
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Figure 31 Cells viability of degradation product of polymer NIPAAm-co-HEMA-co-NAS-coAPLA-co-PAA (PAA-10) and polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-15)
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Figure 32 SEM image of fabricated microspheres
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Figure 33 Oxygen fluorescent intensity of wells incubating the oxygen release microspheres with
the shell of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-5)
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Figure 34 Oxygen fluorescent intensity of wells incubating the oxygen release microspheres with
the shell of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-10)
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Figure 35 Oxygen fluorescent intensity of wells incubating the oxygen release microspheres with
the shell of polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-15)
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Figure 36 dsDNA content of MSCs culture in APLA gel and APLA gel/oxygen release
microspheres (polymer NIPAAm-co-HEMA-co-NAS-co-APLA-co-PAA (PAA-5) as shell) in
hypoxic incubator and in pH=7.4 and pH=6.5 conditions for 14 days.
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3.4 Discussion
The pH-sensitive polymer was synthesized with pH-sensitive species PAA. The reason for the
higher water content in pH=7.4 condition was that the carboxyl functional group on the PAA can
react with abundant hydroxide ion in PBS, which lead to higher hydrophilicity than polymer had
in pH=6.5 PBS. With the significant difference of water content, the hydrolysis of polymer in
pH=7.4 PBS was accelerated. While the microspheres using the polymer as shell structure, with
higher rate of degradation, more H2O2 was released and decomposed by catalase to increase
oxygen level in hypoxia. The curve of oxygen intensity during microspheres were incubated in
hypoxia under pH=6.5 and pH=7.4 environment represented more oxygen in wells that had higher
pH condition. The SEM image showed that the size of microspheres is 3-

3.5 Conclusion
PAA based pH-sensitive oxygen release microspheres were modified to release more oxygen in
slightly basic pH condition, which had the potential of increasing the efficiency of stem cells
treatment for ischemic diseases. Ischemic diseases like brain stroke and heart attack cause
damage to host tissue and change pH microenvironment, which is highly potential method for
preclinical study and clinical experiment.
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Chapter 4 : Future Work
With the pH-sensitive property, microspheres can release oxygen in response to different
microenvironments. However, with the growing demand in new therapeutic treatment for more
efficient restoration and the threaten of various ischemic diseases with high risk of disability
even death, with unique specialization would not satisfy research demands and patients’ wishes.
Further and deeper research could be performed to develop new designs for microspheres to
enhance oxygen release in specific environment, considering various parameters simultaneously
such as oxygen content, local pH and glucose level), Such strategy can be applied to fabricate
microspheres that can recognize multiple harsh microenvironments and control oxygen release in
those conditions.
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